Volume 122, Issue 6 , Pages 1169-1177.e16, December 2008
Hypomorphic nuclear factor-κB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity
Background
Human hypomorphic nuclear factor-κB essential modulator (NEMO) mutations cause diverse clinical and immunologic phenotypes, but understanding of their scope and mechanistic links to immune function and genotype is incomplete.
Objective
We created and analyzed a database of hypomorphic NEMO mutations to determine the spectrum of phenotypes and their associated genotypes and sought to establish a standardized NEMO reconstitution system to obtain mechanistic insights.
Methods
Phenotypes of 72 individuals with NEMO mutations were compiled. NEMO L153R and C417R were investigated further in a reconstitution system. TNF-α or Toll-like receptor (TLR)–5 signals were evaluated for nuclear factor-κB activation, programmed cell death, and A20 gene expression.
Results
Thirty-two different mutations were identified; 53% affect the zinc finger domain. Seventy-seven percent were associated with ectodermal dysplasia, 86% with serious pyogenic infection, 39% with mycobacterial infection, 19% with serious viral infection, and 23% with inflammatory diseases. Thirty-six percent of individuals died at a mean age of 6.4 years. CD40, IL-1, TNF-α, TLR, and T-cell receptor signals were impaired in 15 of 16 (94%), 6 of 7 (86%), 9 of 11 (82%), 9 of 14 (64%), and 7 of 18 (39%), respectively. Hypomorphism-reconstituted NEMO-deficient cells demonstrated partial restoration of NEMO functions. Although both L153R and C417R impaired TLR and TNF-α–induced NF-κB activation, L153R also increased TNF-α–induced programmed cell death with decreased A20 expression.
Conclusion
Distinct NEMO hypomorphs define specific disease and genetic characteristics. A reconstitution system can identify attributes of hypomorphisms independent of an individual's genetic background. Apoptosis susceptibility in L153R reconstituted cells defines a specific phenotype of this mutation that likely contributes to the excessive inflammation with which it is clinically associated.
Key words: NEMO, immunodeficiency, genetic database, Jurkat reconstitution, NF-κB activation, A20
Abbreviations used: 7-AAD, 7-Amino actinomycin D, DC, Dendritic cell, EDA, Ectodermal dysplasia and anhidrosis, EMSA, Electrophoretic mobility shift assay, FACS, Fluorescence-activated cell sorting, GFP, Green fluorescent protein, IKK, IκB kinase, NEMO, Nuclear factor-κB essential modulator, NF-κB, Nuclear factor-κB, pNEMO, Parental nuclear factor-κB essential modulator, rNEMO, Wild-type reconstituted NEMO(-), TCR, T-cell receptor
Supported by National Institutes of Health (NIH) AI079731 (J.S.O.), US Immunodeficiency Network Grant NIH N01 AI-22070 (J.S.O., M.J.M.), NIH HL080612 (M.J.M), the Pennsylvania Department of Health (J.S.O.; the Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusions from this study), a career development award from the American Academy of Allergy, Asthma & Immunology (J.S.O.), NIH 5T32CA009140-33 (E.P.H.), and the Penn Center for Clinical Immunology Jackson-Wade Fellowship (E.P.H.)
Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.
PII: S0091-6749(08)01545-5
doi:10.1016/j.jaci.2008.08.018
© 2008 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 122, Issue 6 , Pages 1169-1177.e16, December 2008
